Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Idiopathic Pulmonary Fibrosis | Research

Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases

Authors: Ségolene Carlier, Mouhamad Nasser, Emmanuel Fort, Céline Lamouroux, Salim Si-Mohamed, Lara Chalabreysse, Jean-Michel Maury, Rémi Diesler, Vincent Cottin, Barbara Charbotel

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Diffuse interstitial lung diseases (ILD) constitute a heterogeneous group of conditions with complex etiological diagnoses requiring a multidisciplinary approach. Much is still unknown about them, particularly their relationship with occupational exposures. The primary objective of this study was to investigate the distribution of occupational exposures according to type of ILD. The secondary objectives were to estimate the proportion of ILDs possibly related to occupational exposure and to evaluate the added value of the participation of an occupational disease consultant in ILD multidisciplinary discussions (MDD).

Methods

From May to December 2020, all consecutive patients with ILD whose cases were reviewed during a MDD in a referral centre for ILD were prospectively offered a consultation with an occupational disease consultant.

Results

Of the 156 patients with ILD whose cases were reviewed in MDD during the study period, 141 patients attended an occupational exposure consultation. Occupational exposure was identified in 97 patients. Occupational exposure to asbestos was found in 12/31 (38.7%) patients with idiopathic pulmonary fibrosis (IPF) and in 9/18 (50.0%) patients with unclassifiable fibrosis. Occupational exposure to metal dust was found in 13/31 (41.9%) patients with IPFs and 10/18 (55.6%) patients with unclassifiable fibrosis. Silica exposure was found in 12/50 (24.0%) patients with autoimmune ILD. The link between occupational exposure and ILD was confirmed for 41 patients after the specialist occupational consultation. The occupational origin had not been considered (n = 9) or had been excluded or neglected (n = 4) by the MDD before the specialised consultation. A total of 24 (17%) patients were advised to apply for occupational disease compensation, including 22 (15.6%) following the consultation. In addition, a diagnosis different from the one proposed by the MDD was proposed for 18/141 (12.8%) patients.

Conclusions

In our study, we found a high prevalence of occupational respiratory exposure with a potential causal link in patients with ILD. We suggest that a systematic specialised consultation in occupational medicine could be beneficial in the ILD diagnostic approach.
Literature
1.
go back to reference Valeyre D, Freynet O, Dion G, Bouvry D, Annesi-Maesano I, Nunes H. Epidémiologie des pneumopathies infiltrantes diffuses [Epidemiology of interstitial lung diseases]. Presse Med. 2010;39(1):53–9.CrossRef Valeyre D, Freynet O, Dion G, Bouvry D, Annesi-Maesano I, Nunes H. Epidémiologie des pneumopathies infiltrantes diffuses [Epidemiology of interstitial lung diseases]. Presse Med. 2010;39(1):53–9.CrossRef
2.
go back to reference Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.CrossRef Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.CrossRef
3.
go back to reference Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement. Am J Respir Crit Care Med. 2019;199(11):1312–34.CrossRef Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement. Am J Respir Crit Care Med. 2019;199(11):1312–34.CrossRef
4.
go back to reference American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691–715.CrossRef American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691–715.CrossRef
5.
go back to reference Romero S, Hernández L, Gil J, Aranda I, Martín C, Sanchez-Payá J. Organizing pneumonia in textile printing workers: a clinical description. Eur Respir J. 1998;11(2):265–71.CrossRef Romero S, Hernández L, Gil J, Aranda I, Martín C, Sanchez-Payá J. Organizing pneumonia in textile printing workers: a clinical description. Eur Respir J. 1998;11(2):265–71.CrossRef
6.
go back to reference Ould Kadi F, Mohammed-Brahim B, Fyad A, Lellou S, Nemery B. Outbreak of pulmonary disease in textile dye sprayers in Algeria. Lancet. 1994;344(8927):962–3.CrossRef Ould Kadi F, Mohammed-Brahim B, Fyad A, Lellou S, Nemery B. Outbreak of pulmonary disease in textile dye sprayers in Algeria. Lancet. 1994;344(8927):962–3.CrossRef
7.
go back to reference Cavalcanti Zdo R, Albuquerque Filho AP, Pereira CA, Coletta EN. Bronchiolitis associated with exposure to artificial butter flavoring in workers at a cookie factory in Brazil. J Bras Pneumol. 2012;38(3):395–9. Cavalcanti Zdo R, Albuquerque Filho AP, Pereira CA, Coletta EN. Bronchiolitis associated with exposure to artificial butter flavoring in workers at a cookie factory in Brazil. J Bras Pneumol. 2012;38(3):395–9.
8.
go back to reference Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002;347(5):330–8.CrossRef Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002;347(5):330–8.CrossRef
9.
go back to reference Centers for Disease Control and Prevention (CDC). Fixed obstructive lung disease among workers in the flavor-manufacturing industry—California, 2004–2007. MMWR Morb Mortal Wkly Rep. 2007;56(16):389–93. Centers for Disease Control and Prevention (CDC). Fixed obstructive lung disease among workers in the flavor-manufacturing industry—California, 2004–2007. MMWR Morb Mortal Wkly Rep. 2007;56(16):389–93.
10.
go back to reference Centers for Disease Control and Prevention (CDC). Obliterative bronchiolitis in workers in a coffee-processing facility—Texas, 2008–2012. MMWR Morb Mortal Wkly Rep. 2013;62(16):305‑7. Centers for Disease Control and Prevention (CDC). Obliterative bronchiolitis in workers in a coffee-processing facility—Texas, 2008–2012. MMWR Morb Mortal Wkly Rep. 2013;62(16):305‑7.
11.
go back to reference Hendrick DJ. “Popcorn worker’s lung” in Britain in a man making potato crisp flavouring. Thorax. 2008;63(3):267–8.CrossRef Hendrick DJ. “Popcorn worker’s lung” in Britain in a man making potato crisp flavouring. Thorax. 2008;63(3):267–8.CrossRef
12.
go back to reference Cullinan P, McGavin CR, Kreiss K, Nicholson AG, Maher TM, Howell T, et al. Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med. 2013;70(5):357–9.CrossRef Cullinan P, McGavin CR, Kreiss K, Nicholson AG, Maher TM, Howell T, et al. Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med. 2013;70(5):357–9.CrossRef
13.
go back to reference Eschenbacher WL, Kreiss K, Lougheed MD, Pransky GS, Day B, Castellan RM. Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med. 1999;159(6):2003–8.CrossRef Eschenbacher WL, Kreiss K, Lougheed MD, Pransky GS, Day B, Castellan RM. Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med. 1999;159(6):2003–8.CrossRef
14.
go back to reference Abraham JL, Hertzberg MA. Inorganic particulates associated with desquamative interstitial pneumonia. Chest. 1981;80(1 Suppl):67–70.CrossRef Abraham JL, Hertzberg MA. Inorganic particulates associated with desquamative interstitial pneumonia. Chest. 1981;80(1 Suppl):67–70.CrossRef
15.
go back to reference Homma T, Ueno T, Sekizawa K, Tanaka A, Hirata M. Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health. 2003;45(3):137–9.CrossRef Homma T, Ueno T, Sekizawa K, Tanaka A, Hirata M. Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health. 2003;45(3):137–9.CrossRef
16.
go back to reference Homma S, Miyamoto A, Sakamoto S, Kishi K, Motoi N, Yoshimura K. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J. 2005;25(1):200–4.CrossRef Homma S, Miyamoto A, Sakamoto S, Kishi K, Motoi N, Yoshimura K. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J. 2005;25(1):200–4.CrossRef
17.
go back to reference Jouneau S, Kerjouan M, Briens E, Lenormand J-P, Meunier C, Letheulle J, et al. La protéinose alvéolaire pulmonaire [Pulmonary alveolar proteinosis]. Rev Mal Respir. 2014;31(10):975–91.CrossRef Jouneau S, Kerjouan M, Briens E, Lenormand J-P, Meunier C, Letheulle J, et al. La protéinose alvéolaire pulmonaire [Pulmonary alveolar proteinosis]. Rev Mal Respir. 2014;31(10):975–91.CrossRef
18.
go back to reference Zhao JH, Duan Y, Wang YJ, Huang XL, Yang GJ, Wang J. The influence of different solvents on systemic sclerosis: an updated meta-analysis of 14 case-control studies. J Clin Rheumatol. 2016;22(5):253–9.CrossRef Zhao JH, Duan Y, Wang YJ, Huang XL, Yang GJ, Wang J. The influence of different solvents on systemic sclerosis: an updated meta-analysis of 14 case-control studies. J Clin Rheumatol. 2016;22(5):253–9.CrossRef
19.
go back to reference Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017;36(3):569–82.CrossRef Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017;36(3):569–82.CrossRef
20.
go back to reference Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, et al. Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls. Autoimmun Rev. 2017;16(3):223–30.CrossRef Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, et al. Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls. Autoimmun Rev. 2017;16(3):223–30.CrossRef
22.
go back to reference Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150): 180076.CrossRef Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150): 180076.CrossRef
23.
go back to reference Letovanec I, Schnyder P, Fellrath J-M. Les pneumopathies interstitielles diffuses chroniques: un mariage de raison entre pathologiste, clinicien et radiologue. [Diffuse parenchymal lung disease, multidisciplinary approach and role of pathology]. Rev Med Suisse. 2007;3(119):1718–22. Letovanec I, Schnyder P, Fellrath J-M. Les pneumopathies interstitielles diffuses chroniques: un mariage de raison entre pathologiste, clinicien et radiologue. [Diffuse parenchymal lung disease, multidisciplinary approach and role of pathology]. Rev Med Suisse. 2007;3(119):1718–22.
24.
go back to reference Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68.
25.
go back to reference Cottin V. Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty. Eur Respir J. 2016;48(5):1274–7.CrossRef Cottin V. Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty. Eur Respir J. 2016;48(5):1274–7.CrossRef
26.
go back to reference Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest. 2021;160(1):209–18.CrossRef Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest. 2021;160(1):209–18.CrossRef
27.
go back to reference Ryerson CJ, Corte TJ, Lee JS, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. An International Working Group Perspective. Am J Respir Crit Care Med. 2017;196(10):1249–54.CrossRef Ryerson CJ, Corte TJ, Lee JS, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. An International Working Group Perspective. Am J Respir Crit Care Med. 2017;196(10):1249–54.CrossRef
28.
go back to reference Walsh SLF, Lederer DJ, Ryerson CJ, et al. Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(9):1146–53.CrossRef Walsh SLF, Lederer DJ, Ryerson CJ, et al. Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(9):1146–53.CrossRef
30.
go back to reference Kim EA, Kang SK. Historical review of the List of Occupational Diseases recommended by the International Labour organization (ILO). Ann Occup Environ Med. 2013;25(1):14.CrossRef Kim EA, Kang SK. Historical review of the List of Occupational Diseases recommended by the International Labour organization (ILO). Ann Occup Environ Med. 2013;25(1):14.CrossRef
32.
go back to reference Guida F, Paget-Bailly S, Lamkarkach F, Gaye O, Ducamp S, Menvielle G, et al. Risk of lung cancer associated with occupational exposure to mineral wools: updating knowledge from a French population-based case-control study, the ICARE study. J Occup Environ Med. 2013;55(7):786–95.CrossRef Guida F, Paget-Bailly S, Lamkarkach F, Gaye O, Ducamp S, Menvielle G, et al. Risk of lung cancer associated with occupational exposure to mineral wools: updating knowledge from a French population-based case-control study, the ICARE study. J Occup Environ Med. 2013;55(7):786–95.CrossRef
33.
go back to reference Koo JW, Myong JP, Yoon HK, Rhee CK, Kim Y, Kim JS, et al. Occupational exposure and idiopathic pulmonary fibrosis: a multicentre case-control study in Korea. Int J Tuberc Lung Dis. 2017;21(1):107–12.CrossRef Koo JW, Myong JP, Yoon HK, Rhee CK, Kim Y, Kim JS, et al. Occupational exposure and idiopathic pulmonary fibrosis: a multicentre case-control study in Korea. Int J Tuberc Lung Dis. 2017;21(1):107–12.CrossRef
34.
go back to reference Paris C, Benichou J, Raffaelli C, Genevois A, Fournier L, Menard G, et al. Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. Scand J Work Environ Health. 2004;30(3):206–14.CrossRef Paris C, Benichou J, Raffaelli C, Genevois A, Fournier L, Menard G, et al. Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. Scand J Work Environ Health. 2004;30(3):206–14.CrossRef
36.
go back to reference Barber CM, Wiggans RE, Young C, Fishwick D. UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occup Med (Lond). 2016;66(2):106–11.CrossRef Barber CM, Wiggans RE, Young C, Fishwick D. UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occup Med (Lond). 2016;66(2):106–11.CrossRef
37.
go back to reference Lee SH, Kim DS, Kim YW, Chung MP, Uh ST, Park CS, et al. Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey. Chest. 2015;147(2):465–74.CrossRef Lee SH, Kim DS, Kim YW, Chung MP, Uh ST, Park CS, et al. Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey. Chest. 2015;147(2):465–74.CrossRef
39.
go back to reference Dodia N, Amariei D, Kenaa B, Corwin D, Chelala L, Britt EJ, et al. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease. Respir Med. 2021;179: 106333.CrossRef Dodia N, Amariei D, Kenaa B, Corwin D, Chelala L, Britt EJ, et al. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease. Respir Med. 2021;179: 106333.CrossRef
40.
go back to reference Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–68.CrossRef Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–68.CrossRef
42.
go back to reference Walsh SLF, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016;4(7):557–65.CrossRef Walsh SLF, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016;4(7):557–65.CrossRef
43.
go back to reference Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18(1):9.CrossRef Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18(1):9.CrossRef
Metadata
Title
Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases
Authors
Ségolene Carlier
Mouhamad Nasser
Emmanuel Fort
Céline Lamouroux
Salim Si-Mohamed
Lara Chalabreysse
Jean-Michel Maury
Rémi Diesler
Vincent Cottin
Barbara Charbotel
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02257-6

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.